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Summary
Objective: Chitosan has been widely used as an injectable scaffold in cartilage tissue engineering due to its characteristic biocompatibility and
biodegradability. In this study, chitosan was used in its hydrogel form as a scaffold for chondrocytes that act to reconstruct tissue-engineered
cartilage and repair articular cartilage defects in the sheep model. This study aims to ﬁnd a novel way to apply chitosan in cartilage tissue
engineering.
Methods: Temperature-responsive chitosan hydrogels were prepared by combining chitosan, b-sodium glycerophosphate (GP) and hydrox-
yethyl cellulose (HEC). Tissue-engineered cartilage reconstructions were made in vitro by mixing sheep chondrocytes with a chitosan hydro-
gel. Cell survival and matrix accumulation were analyzed after 3 weeks in culture. To collect data for in vivo repair, reconstructions cultured for
1 day were transplanted to the freshly prepared defects of the articular cartilage of sheep. Then at both 12 and 24 weeks after transplantation,
the grafts were extracted and analyzed histologically and immunohistochemically.
Results: The results showed that the chondrocytes in the reconstructed cartilage survived and retained their ability to secrete matrix when
cultured in vitro. Transplanted in vivo, the reconstructions repaired cartilage defects completely within 24 weeks. The implantation of chitosan
hydrogels without chondrocytes also helps to repair cartilage defects.
Conclusions: The chitosan-based hydrogel could support matrix accumulation of chondrocytes and could repair sheep cartilage defects in 24
weeks. This study showcased the success of a new technique in its ability to repair articular cartilage defects.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Articular cartilage damage occurs frequently as a result of
sport-related injury, disease, trauma and tumor1. In adult
animals, human beings included, injured cartilage tissue is
unable to heal spontaneously. Failure to treat damaged
tissue may lead to osteoarthritis, pain and malfunction2.
Although a variety of procedures are employed to repair
cartilage damages, current methods of treatment remain
unsatisfactory and inefﬁcient, with chondroectomy3, dril-
ling4, cartilage scraping5, arthroplasty6, transplantation of
autogenic or allogenic chondrocytes7,8, periosteum9 as
well as cartilage and bone ﬂap being the most commonlyaThese authors contributed equally to this work.
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257applied10. Repairing large defects of articular cartilage con-
tinues to be a daunting challenge for clinical surgeons11.
With the development of tissue engineering, reconstruct-
ing cartilage provides a new method of cartilage repair. The
main method employed to engineer cartilage involves the
use of seeding cells and scaffolds. Scaffolds are used be-
cause they provide a three dimensional environment highly
desirable for the production of cartilaginous tissues12. Both
synthetic13e15 and natural16e18 scaffolding materials have
been used for cell delivery in cartilage regeneration.
Many reports exist that detail successful repairs of carti-
lage defects with the use of different synthetic polymers.
However, these materials are ﬂawed with examples being
some of the following reasons: (1) their use involving the
creation and accumulation of acidic by-products; (2) their
low biocompatibility; and (3) the possible toxic by-products
of these materials’ degradation after implantation, which
may elicit an inﬂammatory response19.
In contrast, natural materials often have high levels of
biocompatibility, since their interactions with cells via cell
surface receptors lessen chances for implantation rejection,
258 T. Hao et al.: Chitosan hydrogels for cartilage repairand these materials also are easily biodegraded12. Natural
materials that have been explored as bioactive scaffolds for
cartilage engineering include chitosan20,21, collagen22, ate-
locollagen gel23,24, ﬁbrin25, alginate26, and agarose27et al.
Satisfactory results were obtained for all. Ochi et al. showed
that implanting chondrocytes with the use of an atelocolla-
gen gel could promote restoration of the articular cartilage
of the knee23.
Chitosan is a natural renewable resource. It is composed
of glucosamine and N-acetylglucosamine monomers and
has many attractive properties including biocompatibility,
biodegradability, non-toxicity, physiological inertness, re-
markable afﬁnity to proteins, bacterial resistance, and hae-
mostaticity. It also improves wound-healing activity in the
connective tissues of several species28. Furthermore, chito-
san shares some characteristics with articular cartilage,
e.g., various glycosaminoglycan (GAGs) and hyaluronic
acid29, making it an ideal scaffolding material in articular
cartilage engineering. Hoemann et al.30 reconstructed tis-
sue-engineered cartilage in vitro for transplantation into
a nude mouse by using injectable temperature-responsive
chitosan as a scaffold. They also injected the chitosan
alone into rabbit articular cartilage to repair defects. Optimal
results were obtained after at least 1 week in vivo. Chervier
et al.31 showed improved cartilage repairs upon the applica-
tion of chitosan-GP/blood implants to the marrow-stimulated
cartilage lesions. These studies suggested that chitosan
hydrogel was a desirable scaffold to use to repair cartilage
defects. However, since the injected chitosan needs at least
10 min to gel after transplantation, it may ﬂow out of the joint
cavity, resulting in the formation of cartilage-like tissue
ectopically. This can cause complications like pain, there-
fore, injection may not be the best way to deliver chitosan
to articular cartilage defects32. Ito et al. repaired osteochon-
dral defects in the rabbit model with a tissue-engineered
chondral plug made of atelocollagen sponge and Poly-L-
Lactide-Acid mesh. The chondral plug could be adjusted
to the proper shape and orientation to ﬁt the intrinsic de-
fect24. This kind of ‘‘in situ forming’’ approach could help
solve the aforementioned problems that pertain to using
chitosan as a scaffold. In this study, we have reconstructed
tissue-engineered cartilage in vitro by using temperature-re-
sponsive chitosan hydrogels as scaffolds before transplan-
tation in vivo. The reconstructions could avoid liquid
chitosan runoff into the articular cavity, and could be easily
modiﬁed to adapt to the shape of the defects12. We used
autologous chondrocytes as the seeding cells and sheep
as the experimental animals. No report on the same topic
has been discovered by the author yet.MethodsANIMALS AND GROUPSTwenty four skeletally mature and healthy sheep (male or female, 8e12
months old, 20e25 kg mean body weight) were provided by the Experimen-
tal Animals Center of the Beijing Institute of Basic Medical Sciences, and
were kept in a controlled environment with access to food and water. All
experiments were approved by the Animal Experimental Committee of the
Beijing Institute of Basic Medical Sciences.
The sheep were randomly divided into three groups. In the experimental
group (n¼ 12), the sheep were implanted with the tissue-engineered carti-
lage. In control group 1 (n¼ 6), the sheep were implanted with chitosan
hydrogel. The sheep with the untreated defects served as control group 2
(n¼ 6).ISOLATION OF CHONDROCYTESIn the experimental group, all animals were anesthetized through intra-
muscular administration of ketamine (0.01 mg/kg). The articular cartilagetissue was cut off from the left knee joint of the non-weight-bearing areas
of the sheep, and then minced into pieces of about 1 mm3. The minced car-
tilage tissue was transferred to a glass spinner ﬂask containing H-DMEM
(Invitrogen, Carlsbad, Calif) with 25 mM HEPES (Sigma, St. Louis, MO),
1.5 mg/ml collagenase II (Sigma, St. Louis, MO) and spun on a magnetic stir-
rer at 37C for 8e12 h. The obtained cell suspension was ﬁltered through
a 120 mm pore size nylon mesh ﬁlter and washed twice with phosphate-buff-
ered saline (PBS). The chondrocytes were harvested by centrifugation at
1500 rpm for 5 min. Cell number and viability were determined by means
of a hemocytometer and trypan blue vital dye. The chondrocytes were
cultured in H-DMEM and 10% fetal bovine serum (Hyclone, Logan, UTA)
in an incubator at 37C, 5% CO2. All manipulations were performed under
sterile conditions. We collected chondrocytes of passage three to serve as
seeding cells.FORMULATION OF CHITOSAN HYDROGELThe temperature-responsive chitosan hydrogel was prepared according
to Hoemann CD et al.30 Chitosan was obtained from Pronova (Oslo, Norway,
Product No UP CL 113 degree of deacetylation (DDA): 86%; 12%HCl; appar-
ent viscosity: 16 mPa.s; dry matter content: 96.0%; Endotoxins: 230EU/
gram). Protasan UP113 powder was dissolved in the distilled water at
2%(w/v) chitosan, then autoclave sterilized. The chitosan solutions were
mixed with concentrated stock solutions of ﬁlter-sterilized b-sodium glycero-
phosphate (GP, Sigma, 11.5%w/v, molecular weight: 216.04), to yield a liquid
chitosan-GP solution with 1.6% chitosan, 108 mM GP. The ﬁnal pH is 6.8.
Chitosan hydrogels were formed by mixing 10 ml chitosan-GP solution
with 2.5 ml cross-linking solution consisting of 2.5% (w/v in H-DMEM) ﬁlter-
sterilized hydroxyethyl cellulose (HEC) (Fluka, St. Louis, MO, viscosity:
1500 mPa.s). They were incubated at 37C for 10e15 min.RECONSTRUCTION OF TISSUE-ENGINEERED CARTILAGE
IN VITROAbout 4 107 chondrocytes were mixed with 1 ml chitosan hydrogel and
poured into a 4-well cell culture plate, and then incubated at 37C for
10e15 min to allow it to gel. We constructed 15 pieces of tissue-engineered
cartilage altogether at one time. After 1 day of in vitro culture, 12 pieces were
transplanted to the defects in vivo to aid repairs. Cell viability in the hydrogel
was assessed by using acridine orange-propidium iodide (AO/PI) staining.
Brieﬂy, the stock solution (AO: 670 mmol/L, PI: 750 mmol/L) was prepared
with Dulbeccos solution and kept in the dark at 4C. Just before use,
0.01 ml AO and 1.0 ml PI were mixed, diluted by 10 times with Dulbeccos so-
lution, and then passed through a 0.22 mm ﬁlter membrane. The hydrogels
containing chondrocytes were incubated with the AO/PI mixture for 10 min
and observed under a ﬂuorescence microscope. Live cells were stained in
green (AO) whereas dead cells were colored red (PI). To ﬁnd the accumula-
tion of matrix in the tissue-engineered cartilage, the remaining three pieces of
reconstructed tissue were cultured in vitro for 3 weeks and analyzed by using
hematoxylin and eosin (H.E.), toluidine blue, safranin O and type II collagen
immunohistochemical staining.BIOMECHANICAL PROPERTIES OF RECONSTRUCTED
CARTILAGE IN VITROBiomechanical properties of tissue-engineered cartilage were assessed
via stress-relaxation tests in uniaxial, unconﬁned compression using the
Mach-1 micromechanical testing system (BioSyntech, Laval, QC) accord-
ing to Hoemann CD et al.30. For reconstructed cartilage cultured in vitro, two
successive compression ramps each with an amplitude corresponding to
10% of the sample thickness were applied at a strain rate of 1%/s. Equilib-
rium was estimated when the load changed by less than 0.05 g/min.
Stress-relaxation curves from the second ramp (10e20% strain) of recon-
structed cartilage were ﬁt to a ﬁbril reinforced poroelastic model to obtain
the compressive equilibrium modulus (Em) and tensile ﬁbril modulus (Ef).AUTOLOGOUS TRANSPLANTATION OF TISSUE-ENGINEERED
CARTILAGEAll animals were anesthetized through intramuscular administration of ket-
amine (0.01 mg/kg). The right rear limb was shaved and then disinfected. A
4 cm-long incision was made over the right knee of each animal. The patella
was dislocated laterally. The knee was ﬂexed 90 to expose the non-weight-
bearing area of the medial femoral condyle. One defect, 8 mm in diameter
and 3 mm in depth, was created mechanically with a hollow trephine (exter-
nal diameter, 8 mm). The depth of penetration was limited to 3 mm by a line
marked on the hollow trephine. In the experimental group, the defects were
ﬁlled with the corresponding construction of tissue-engineered cartilage. In
control group 1, the defects were ﬁlled only with the chitosan hydrogel. In
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tion. The joint cyst was carefully closed by precise suturing. The soft tissue
ﬂap was sutured to its original site. All animals received an injection of
160,000 units of penicillin for 3 days and allowed free movement post-oper-
ation. At 12 and then 24 weeks after implantation, half of the total number of
sheep was killed each time by intravenous injection of a lethal dose of bar-
biturate. The knee joints were removed for further study.HISTOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATIONThe harvested samples were ﬁrst examined grossly and photographed,
and then were sawn apart through the center of the defects into several sli-
ces e cartilage defect, adjacent cartilage, and underlying bone. Most of the
slices were immersed in 4% paraformaldehyde buffer (pH 7.4) for histological
examination. The rest with cartilage defects were frozen in liquid nitrogen for
biochemical analysis.
The dissected samples perpendicular to the surface of the implantation
sites were dehydrated through successive concentrations of alcohol (70%
up to absolute). The blocks were cleared in xylene before being embedded
in parafﬁn and then were cut with a microtome (RM2165 rotary microtome;
Leica Microsystems, Nussloch, Germany). The samples were sectioned to
5 mm and stained with H.E., toluidine blue, safranin O/fast green and type
II collagen immunohistochemical stains.
For immunohistochemistry, the sections were washed in PBS, digested
with 0.1% trypsin for 30 min at 37C, and then pretreated with 5% goat serum
(GS) for 20 min at room temperature to block nonspeciﬁc reactions. Poly-
clonal antibodies to type II collagen (Maixin, Fujian, China) were incubated
with the sections for 60 min. The sections were rinsed in PBS and incubated
with post-blocking (Maixin, Fujian, China) for 20 min. They were then rinsed
three times with PBS, treated for 30 min with poly-HRP Anti-Ms/Rb IgG
(Maixin, Fujian, China), rinsed three times with PBS, and treated for
5e10 min with 0.02% diaminobenzidine in 0.01 M Tris buffer (pH 7.6) con-
taining 0.005% H2O2.
The specimens were graded semiquantitatively on the basis of the
predominant nature of the repaired tissue, matrix staining, regularity of the
surface structural integrity, thickness of the repair, apposition between the re-
paired cartilage and the surrounding normal cartilage, freedom from degen-
erative changes in the repair tissue, and freedom from the surrounding
normal cartilage as described by O’ Driscoll et al.34 Differences in histological
scoring between groups were analyzed by ANOVA. Statistical analyses were
performed with SPSS 11.0. Signiﬁcance was accepted at P< 0.01. Results
are reported as mean standard deviation.BIOCHEMICAL ANALYSISFrozen samples were carefully crushed and digested with papain
(0.5 mg/ml; Sigma) at 65C for 4 h. A 50 ml sample of digested tissue was
mixed with 2.5 ml of Alcian blue (Sigma, St. Louis, MO). The samples
were analyzed with a spectrophotometer (DU640; Beckman Coulter, Fuller-
ton, CA) at an optical wavelength of 480 nm. The amount of GAG present in
the harvested tissue was determined at 480 nm by comparing it with a chon-
droitin sulfate (Sigma, St. Louis, MO) standard curve33. Statistical analysis
was performed with the SPSS 11.0. Data are shown as mean standard
deviation. A t-test was performed to analyze the different amounts of
GAG between the experimental group and the control groups. Differences
at P< 0.01 were considered signiﬁcant.ResultsFORMULATION OF CHITOSAN HYDROGEL AND
RECONSTRUCTION OF TISSUE-ENGINEERED
CARTILAGE IN VITROThe temperature-responsive chitosan hydrogels were
kept in liquid [Fig. 1(A)] at room temperature and then solid-
iﬁed [Fig. 1(B)] at 37C for 10e15 min. The size of the re-
constructed cartilage approximates that of the well of the
4-well plate [Fig. 1(C)]. The AO/PI staining showed that
the chondrocytes remained >90% viable in the chitosan
matrix after being cultured for 1 day in vitro [Fig. 1(D)].ACCUMULATION OF MATRIX IN THE TISSUE-ENGINEERED
CARTILAGEThe results showed that the chondrocytes in the chitosan
hydrogels accumulated pericellular sulfated GAG-containingmatrix. H.E. staining showed that the chondrocytes in the
chitosan hydrogels were normal in appearance [Fig. 2(A)].
Moreover, in the chitosan hydrogel, we also observed
type II collagen immunohistochemical staining activity
[Fig. 2(B)]. The toluidine blue staining and safraninO staining
indicated that chondrocytes could produce the cartilage
matrix in the chitosan hydrogels [Fig. 2(C, D)].BIOMECHANICAL PROPERTIES OF RECONSTRUCTED
CARTILAGE IN VITROThe biomechanical properties of the reconstructed carti-
lage after 0 days and after 1 day of in vitro culture were
assessed. The results showed that although the mechanical
properties of the reconstructed cartilage increasedafter 1 day
of culture compared with that of 0 day of culture (Table I), the
mechanical properties (Em and Ef) of reconstructed cartilage
remained signiﬁcantly inferior to native tissue (the data were
previously reported by Hoemann CD et al.30).GROSS OBSERVATION OF THE ARTICULAR CARTILAGE
REPAIR 24 WEEKS POST-OPERATIONAll animals survived the follow-up period of 12 or 24 weeks
without signs of major wound infection, limited range of mo-
tion, or synovitis in the operated knees. No free tissue-engi-
neered cartilage was found outside of the cartilage defects
in the joint cavity. At 12 weeks post-operation, most of the de-
fects treated with tissue-engineered cartilage in the experi-
mental group were repaired, leaving a relatively consistent
and smooth joint surface. At 24 weeks post-operation, the de-
fected part of the cartilage in the experimental group was cov-
ered by the smooth, consistent, glistening white hyaline tissue
almost indistinguishable from the surrounding normal carti-
lage. No clear signs of margin with normal cartilage could be
spotted on the surface of the regenerated areas [Fig. 3(A)].
In contrast, the defects in control group 1 were partially re-
paired with ﬁber-like tissue, leaving a small depression in
the defect areas [Fig. 3(B)]. And the defects in control group
2 detected a thin and irregular surface tissue with obvious de-
fects and cracks surrounding the normal cartilage [Fig. 3(C)].HISTOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATION
OF THE ARTICULAR CARTILAGE REPAIRIn the experimental group, H.E. staining displayed the
boundary of original and renewed cartilage 12 weeks
post-operation. The cells in the renewed cartilage were
somewhat different from those in the normal cartilage tissue
[Fig. 4(A)]. The formation of cartilage-like tissue could
be seen through toluidine blue staining and safranin O
staining, indicating a considerable amount of proteoglycan
[Fig. 4(B,C)]. In control group 1, the defect areas were ﬁlled
with the remaining chitosan surrounded by ﬁbrocartilage tis-
sues [Fig. 4(D)]. It seemed that no cartilage-like tissue was
formed [Fig. 4(E, F)]. In control group 2, H.E. staining
showed that there were no typical cells [Fig. 4(G)], the neg-
ative toluidine blue staining indicated that no cartilage tissue
existed [Fig. 4(H)], but a small quantity of ﬁbrous tissues
could be seen along the margin of defects [Fig. 4(I)].
At 24 weeks post-operation, H.E. staining showed that
the newly-formed cartilage had matured. The cells of the
new cartilage were similar to those of normal chondrocytes
[Fig. 5(A)]. The regenerated hyaline-like cartilage had less
intensive toluidine blue staining than adjacent normal carti-
lage [Fig. 5(B)]. The typical structure of hyaline cartilage
Fig. 1. Formulation of chitosan hydrogel and reconstruction of tissue-engineered cartilage in vitro. A, In room temperature, the chitosan hydro-
gels were keep in liquid; B, The chitosan hydrogels kept at 37C in 10e15 min were solidiﬁed; C, The reconstructed cartilage in the 4-well
plate; D, The AO/PI staining showed that the chondrocytes remained >90% viable in the solid chitosan matrix after cultured 1 day in vitro,
AO: green; PI: red. Bar¼ 0.5 cm(C); 100 mm (D).
Fig. 2. Accumulation of matrix in the tissue-engineered cartilage. Histology and immunohistochemistry of chondrocytes cultured in chitosan
hydrogels 3 weeks. The results showed that the chondrocytes in the chitosan hydrogels accumulated pericellular sulfated GAG-containing
matrix. A, H.E. staining; B, Type II collagen immunohistochemical staining; C, Toluidine blue staining; D, Safranin O staining. Star: chitosan
hydrogel; Arrowhead: cell nucleus; Arrow: matrix of the chondrocytes. Bar¼ 100 mm.
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Table I
Mechanical properties of reconstructed cartilage in vitro
Days cultured Reconstructed cartilage
0 day (n¼ 4) 1day (n¼ 4)
Em (equilibrium modulus, kPa) 1.5 0.2 5.1 0.6
Ef (ﬁbril modulus, kPa) 40 16 110 9
261Osteoarthritis and Cartilage Vol. 18, No. 2lacunae was apparent in the regenerated area [Fig. 5(C)].
The regenerated surface was demonstrated to be hyaline-
like by type II collagen immunohistochemical staining
[Fig. 5(D)]. In control group 1, no chitosan hydrogels were
observed [Fig. 5(E)]. The defects were partly ﬁlled with
some renewed tissues when modestly stained with toluidine
blue and safranin O/fast green. The renewed tissue was
proved to be cartilage [Fig. 5(F, G)], yet type II collagen
immunohistochemical staining showed the cartilage to be
ﬁbrocartilage other than hyaline-like cartilage [Fig. 5(H). In
control group 2, the defect areas remained empty, with
H.E. staining indicating that no cells existed in the defect
areas [Fig. 5(I)]. The negative staining by toluidine blue, saf-
ranin O/fast green showed that the cartilage defects con-
tained only loose ﬁbrous tissues [Fig. 5(J, K)]. So did
Type II collagen immunohistochemical staining [Fig. 5(L)].BIOCHEMICAL ANALYSISGAGcontent is shown in Table II and Table III. GAGwas at
76% and 85% of the content for normal cartilage in tissue-
engineered cartilage at 12 and 24 weeks post-operation
respectively. In contrast, such content in the other two groups
was much lower. Statistical analysis demonstrated a signiﬁ-
cant difference between the experimental group and the
two control groups (P< 0.01) at both 12 and 24 weeks
post-operation. A slight difference was also noted between
the experimental group and normal cartilage (P< 0.05).STATISTICAL ANALYSISThe mean histological scores were 17.5 1.87 (12
weeks post-transplantation) and 22.2 1.17 (24 weeksFig. 3. Gross observation of the articular cartilage repair at 24 weeks po
group was covered by the smooth, consistent, glistening white hyaline tis
No clear signs of margin with normal cartilage could be spotted on the surf
partially repaired with ﬁber-like tissue, leaving a small depression in the d
irregular surface tissue, with obvious defects and cracks surrounpost-transplantation) in the experimental group, 3.5 1.87
(12 weeks post-transplantation) and 13.5 1.38 (24 weeks
post-transplantation) in control group 1, and 2.17 1.20 (12
weeks post-transplantation) and 10.5 1.87 (24 weeks
post-transplantation) in control group 2 (Table IV). The
scores of the experimental group were signiﬁcantly different
when compared with control groups 1 and 2 (P< 0.01).
These results indicated that the tissue-engineered cartilage
formed with chitosan hydrogel had desirable defect-repair-
ing capabilities.Discussion
Cartilage tissue engineering provided a novel and ideal
method for the repair of cartilage defects12, marking break-
throughs in the areas of stem cell treatment, biomaterials,
and biomechanics. The utilization of new materials for tis-
sue-engineered cartilage scaffolds is a priority of scientiﬁc
research28. In this study, we reconstructed tissue-engi-
neered cartilage by using temperature-responsive chitosan
hydrogels as scaffolds, and after a short-term in vitro cul-
ture, transplanted the reconstructed tissue into big animal
models to repair articular cartilage defects. In just 24 weeks
after transplantation, the cartilage defects were repaired
completely. The results indicated that the tissue-engineered
cartilage using temperature-responsive chitosan hydrogel
as a scaffold evidently possessed the ability to repair carti-
lage defects.
The preparation method and choice of scaffold material
were key to the development of these tissue-engineered
constructs. The scaffolds provided a 3-dimensional environ-
ment for the chondrocytes’ in vitro and in vivo cultures. They
could also support the matrix production of chondrocytes35.
Over the past few years, hydrogel materials, especially nat-
ural hydrogel materials, have become more and more at-
tractive for use in tissue engineering. There are some
kinds of hydrogels used speciﬁcally for cartilage tissue
engineering, such as chitosan hydrogels36, alginate hydro-
gels37, polymer oligo(poly(ethylene glycol) fumarate)
(OPF) hydrogels38, and poly(ethylene glycol)-based
(PEGDA) photopolymerizing hydrogels39. Among these
scaffold materials, chitosan may be one of the betterst-operation. A, the defect part of the cartilage in the experimental
sue nearly indistinguishable from the surrounding normal cartilage.
ace of the regenerated areas; B, The defects in control group 1 were
efect areas; C, The defects in control group 2 detected a thin and
ding the normal cartilage. Arrow: the defect; Bar¼ 0.5 cm.
Fig. 4. Histological evaluation of the articular cartilage repair at 12 weeks post-operation. (AeC), In experimental group, H.E. staining dis-
played that the boundary of normal cartilage and renewed cartilage. The cells in the renewed cartilage were somewhat different from those
in the normal cartilage tissue (A); The formation of cartilage-like tissue could be seen with toluidine blue (B) staining and safranin O staining
(C), indicating a considerable amount of proteoglycan; (DeF), In control group 1, the defect areas were ﬁlled with the remaining chitosan hy-
drogels materials surrounded by ﬁbrocartilage tissues (D). It seemed that no cartilage-like tissue was formed as shown by toluidine blue (E)
staining and safranin O staining (F); (GeI), In control group 2, H.E. staining showed that there were no typical cells (G), the negatively toluidine
blue staining indicated that no cartilage tissue (H), but only a small quantity of ﬁbrous tissues could be seen along the margin of defects (I).
Dotted line indicated the boundary of the normal cartilage and the renewed cartilage. Bar¼ 100 mm.
262 T. Hao et al.: Chitosan hydrogels for cartilage repairchoices due to its desirable biocompatibility and biodegrad-
ability. The chitosan hydrogel has two types: temperature-
responsive and UV-radiation-responsive40. Reports show
that temperature-responsive chitosan hydrogels were able
to repair cartilage lesions30,31, therefore we used tempera-
ture-responsive chitosan hydrogels as the chondrocytes’
scaffold to reconstruct tissue-engineered cartilage in vitro.
Transplantation of these reconstructions to repair the carti-
lage defects of big animals proved successful. At both 12
and 24 weeks, the results showed that the chitosan hydro-
gel could enhance ability for repairs in adult cartilage. Nev-
ertheless, the results were even better when the hydrogel
contained chondrocytes. At 24 weeks post-operation, the
defected part of the cartilage in the experimental group
was completely repaired with hyaline cartilage tissue. H.E.
staining showed that the newly-formed cartilage had
matured [Fig. 5(A)]. The regenerated hyaline-like cartilage
had less intensive toluidine blue staining than adjacent
normal cartilage [Fig. 5(B)]. The typical structure of hyaline
cartilage lacunae was apparent in the regenerated area[Fig. 5(C)]. The regenerated surface was demonstrated to
be hyaline-like by type II collagen immunohistochemical
staining [Fig. 5(D)].These results demonstrated that chito-
san hydrogels are applicable to cartilage tissue
engineering.
Biocompatibility of the chitosan hydrogel greatly impacts
the repairs of defects in the regenerated tissue-engineered
cartilage41. The viscosity, DDA and content of endotoxic
products in chitosan affects the biocompatibility of the
hydrogel. The results from the 3 week long in vitro chitosan
hydrogel with autologous chondrocytes co-culture were sat-
isfactory, since the chondrocytes in chitosan hydrogel
retained normal growth and the ability to secrete certain
matrix. H.E. staining showed that the chondrocytes in the
chitosan hydrogels were normal in appearance [Fig. 2(A)].
In the chitosan hydrogel, we also observed type II collagen
immunohistochemical staining activity [Fig. 2(B)]. The tolui-
dine blue staining and safranin O staining indicated that
chondrocytes could produce the cartilage matrix in the chi-
tosan hydrogels [Fig. 2(C, D)]. These results indicated that
Fig. 5. Histological and immunohistochemical evaluation of the articular cartilage repair at 24 weeks post-operation. (AeD), In experimental
group, H.E. staining showed that newly-formed cartilage became more mature. The cells in the newly cartilage were similar to the normal
chondrocytes (A). The regenerated hyaline-like cartilage had less intensive toluidine blue staining than adjacent normal cartilage (B). A typical
structure of hyaline cartilage lacunae is apparent in the regenerated area (C). The regenerated surface was demonstrated to be hyaline-like by
type II collagen immunohistochemical staining (D); (EeH), In control group 1, no chitosan hydrogels were observed (E). The defects were
partly ﬁlled with some renewed tissues when modestly stained with toluidine blue (F) and safranin O/fast green (G). Type II collagen immu-
nohistochemical staining showed the cartilage to be ﬁbrocartilage other than hyaline-like cartilage (H); (IeL), In control group 2, H.E. staining
indicated that the defect areas have no cells existence (I). The negative staining by toluidine blue (J), safranin O/fast green (K) showed that the
cartilage defects containing only some loose ﬁbrous tissues. Type II collagen immunohistochemical staining contained the same (L). Dotted
line indicated the boundary of the normal cartilage and the renewed cartilage. Bar¼ 100 mm.
263Osteoarthritis and Cartilage Vol. 18, No. 2chitosan hydrogel has desirable biocompatibility. It could
provide a comfortable 3-dimensional environment for the
seeded chondrocytes.
The mechanical intensity of the scaffold is one of the
factors that affects the repair of cartilage defects with use
of reconstructed cartilage. It was reported that the mechan-
ical intensity may inﬂuence the defect-repairing ability of tis-
sue-engineered cartilage to some extent42. Hoemann et al.
assessed the biomechanical properties of reconstructed
cartilage via stress-relaxation tests in uniaxial, unconﬁned
compression in vitro and in vivo, with the results showingTable I
Quantification of GAGs 12 we
Joint Normal cartilage Experimental grou
1 138 112
2 146 106
3 140 105
4 142 110
5 141 102
6 144 115
Mean 141.83 2.86 108.33 4.84*
*Differences (P< 0.05) between the experimental group and normal c
ySigniﬁcant differences (P< 0.01) between the experimental group and
by t test.that mechanical properties of these in vitro and in vivo con-
structs remain signiﬁcantly inferior to those of native tissue,
but this did not affect its persistence in osteochondral de-
fects for at least 1 week in vivo30. In this study, the tissue-
engineered cartilage was reconstructed using the same
method as in Hoemann’s study. The reconstructed cartilage
was transplanted 1 day after culture, so the biomechanical
properties of the reconstructed cartilage after 0 days and af-
ter 1 day of in vitro culture were assessed. The results
showed that the mechanical properties of the reconstructed
cartilage also remained signiﬁcantly inferior to native tissue.I
eks post-transplantation
p Control group 1 Control group 2
12 15
12 9
18 11
16 10
15 8
16 11
14.83 2.40y 10.67 2.42y
artilage were revealed as analyzed by t test.
either control group 1 or control group 2 were revealed as analyzed
Table III
Quantification of GAGs 24 weeks post-transplantation
Joint Normal cartilage Experimental group Control group 1 Control group 2
1 142 125 48 28
2 145 123 47 34
3 141 114 51 33
4 136 120 50 24
5 147 118 45 28
6 139 120 44 27
Mean 141.67 3.98 120.00 3.85* 47.50 2.74y 29.00 3.79y
*Different (P< 0.05) between the experimental group and normal cartilage were revealed as analyzed by t test.
ySigniﬁcantly different (P< 0.01) between the experimental group and either control group 1 or control group 2 were revealed as analyzed
by t test.
Table IV
Histological scores of experimental and control groups
Number Experimental group Control group 1 Control group 2
12 weeks 24 weeks 12 weeks 24 weeks 12 weeks 24 weeks
1 18 22 2 13 3 8
2 16 22 1 12 1 11
3 19 21 4 12 2 13
4 15 23 6 15 4 12
5 20 21 3 15 2 9
6 17 24 5 14 1 10
Mean 17.5 1.87* 22.2 1.17* 3.5 1.87 13.5 1.38 2.17 1.17 10.5 1.87
*Signiﬁcantly different (P< 0.01) between the experimental group and either control group 1 or control group 2 were revealed as analyzed
by analysis of variance (ANOVA).
264 T. Hao et al.: Chitosan hydrogels for cartilage repairIn addition, the results from the autologous chondrocyte im-
plantation (ACI), a study on the injection of scaffold-free
chondrocytes, which is already approbated by the Food
and Drug Administration (FDA)43, were available with up
to a 16-year follow-up examination. More than 80% of the
patients have shown improvement with relatively few com-
plications9. Furthermore, the scaffold of matrix-autologous
chondrocyte implantation (MACI) was I/III collagen mem-
brane44 that had insufﬁcient mechanical intensity, yet the
results from MACI were satisfactory. So we suggested
that the mechanical intensity of the scaffolds was not the
only factor important in tissue-engineered cartilage repairs.
Nevertheless, we still expect to see experiments in future
studies that are able to increase the mechanical intensity
of reconstructed cartilage.
In the ﬁeld of cartilage repair or replacement, tissue engi-
neering may hold much inﬂuence in the future9. Many new
materials and medical technologies are being developed to
aid the regeneration of healthy tissues after cartilage dam-
age45. In this study, tissue-engineered cartilage via combin-
ing a novel, natural scaffold technology with autologous
chondrocytes proved to have great potential for regenerating
damaged knee cartilage in the animal model in vivo.
However, the widespread clinical efﬁcacy of this treatment
modality continues to be hampered by several problems,
such as the mechanical intensity strength of the scaffolds,
cell proliferation ability and implantation difﬁculties46. Thus,
in view of these challenges, future research is anticipated.Conﬂict of interest
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